We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Novel Testing Method Detects HIV and Hepatitis B/C from Single Drop of Blood

By LabMedica International staff writers
Posted on 14 Apr 2023

Every year, over one million people succumb to hepatitis B or hepatitis C, while 650,000 die from HIV-related causes and 1. More...

5 million contract HIV. The World Health Organization aims to eliminate all three viruses by 2030, requiring new testing methods to decrease case numbers. The most common test for hepatitis B, hepatitis C, and HIV involves drawing blood from a vein with a needle. However, this approach is not always suitable in prisons, drug rehabilitation centers, and homeless shelters or in countries where blood sample shipping and refrigerated storage pose challenges. Alternative methods, such as dried blood spot tests, can detect nucleic acid from the three viruses in a single blood spot.

At this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark, (April 15–18), researchers at Copenhagen University Hospital (Copenhagen, Denmark) presented data on a test capable of detecting HIV, hepatitis B, and hepatitis C using a single drop of blood. The test involves pricking the individual's finger, collecting a few blood spots on filter paper, and allowing them to dry. The Hologic Panther System, commonly found in public health laboratories, then employs transcription mediated amplification to analyze one blood spot for genetic material from the three viruses.

The researchers assessed the test by analyzing 20 samples containing known amounts of HIV, hepatitis B, and hepatitis C using the dried blood spot method (60 samples in total) and successfully detected the viruses in all samples. Plasma dilution determined the lower detection limit, revealing the capability to detect the viruses at levels significantly lower than those typically found in untreated patients.

“We've shown that using existing hospital equipment, it is possible to detect HIV, hepatitis B and hepatitis C from a single drop of blood,” said Stephen Nilsson-Møller at the Department of Clinical Microbiology, Copenhagen University Hospital. “The dried blood spot test is ideal for places where you don't want to use a needle for safety reasons or where it is less practical. It is also suitable for developing countries or places where you run the risk of a blood sample being ruined before it is transferred to a laboratory that can analyze it. Blood samples need to be analyzed within six hours when kept at room temperature, while dried blood spots can last for nine months without refrigeration.”

Related Links:
Copenhagen University Hospital


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.